4v0p: Difference between revisions

<table><tr><td colspan='2'>[[4v0p]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4V0P OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4V0P FirstGlance]. <br>

</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4v0p FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4v0p OCA], [https://pdbe.org/4v0p PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4v0p RCSB], [https://www.ebi.ac.uk/pdbsum/4v0p PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4v0p ProSAT]</span></td></tr>

[https://www.uniprot.org/uniprot/MAGA3_HUMAN MAGA3_HUMAN] Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. May enhance ubiquitin ligase activity of TRIM28 and stimulate p53/TP53 ubiquitination by TRIM28. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. May play a role in embryonal development and tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes.<ref>PMID:20864041</ref>  

[[Category: Homo sapiens]]

[[Category: Aitkenhead H]]

[[Category: Arrowsmith CH]]

[[Category: Bountra C]]

[[Category: Cooper CDO]]

[[Category: Edwards A]]

[[Category: Gileadi O]]

[[Category: Newman JA]]

[[Category: Pinkas DM]]

[[Category: Von Delft F]]